Table 3.
Mean of inhibitory growth rate (%) ±SD of a pathogenic F. oxysporum with the tested compounds: All control plates have 100 ± 0 growth rate on the 8th day of cultivation.
| Tested Compounds/ Control antifungal |
Concentration
µg/mL |
Inhibition rate (%)± SD |
||
|---|---|---|---|---|
| 4 days | 6 days | 8 days | ||
| 2a | 1 | 40.12 ± 1.70 | 42.13 ± 2.1 | 42.12 ± 4.1# |
| 10 | 42.13 ± 1.03 | 42.01 ± 1.2 | 42.65 ± 1.2 | |
| 50 | 43.55 ± 1.5 | 43.10 ± 1.2 | 44.2 ± 2.1* | |
| 3a | 1 | 80.12 ± 1.33 | 80.12 ± 2.2 | 81.29 ± 1.9# |
| 10 | 81.22 ± 1.20 | 82.33 ± 2.5 | 83.12 ± 2.5 | |
| 50 | 83.21 ± 1.7 | 83.77 ± 1.2 | 84.0 ± 1.9 * | |
| 3b | 1 | 79.15 ± 2.30 | 80.24 ± 3.1 | 82.34 ± 0.5# |
| 10 | 80.93 ± 2.49 | 82.07 ± 2.5 | 84.13 ± 1.5 | |
| 50 | 82.72 ± 2.8 | 87.77 ± 2.8 | 88.8 ± 2.5* | |
| 3c | 1 | 81.25 ± 2.30 | 82.25 ± 7.1 | 83.34 ± 2.5# |
| 10 | 82.83 ± 2.49 | 83.07 ± 1.8 | 85.13 ± 2.5 | |
| 50 | 86.72 ± 2.8 | 87.95 ± 2.8 | 89.9 ± 1.5* | |
| 3d | 1 | 70.12 ± 2.23 | 70.11 ± 3.1 | 71.12 ± 1.5# |
| 10 | 71.15 ± 1.5 | 71.12 ± 2.1 | 72.14 ± 1.5 | |
| 50 | 73.12 ± 1.5 | 73.00 ± 1.1 | 73.22 ± 1.5 | |
| 4a | 1 | 72.12 ± 1.62 | 72.21 ± 3.2 | 72.10 ± 2.4# |
| 10 | 72.16 ± 2.31 | 72.21 ± 1.4 | 72.33 ± 2.5 | |
| 50 | 73.13 ± 2.5 | 73.12 ± 3.0 | 73.0 ± 1.0 | |
| 4d | 1 | 65.35 ± 1.5 | 73.0.5 ± 1.09 | 78.37 ± 2.1# |
| 10 | 71.21 ± 1.5 | 74.153 ± 1.09 | 78.5 ± 0.33 | |
| 50 | 76.95 ± 2.1 | 78.17 ± 1.08 | 80.12 ± 0.5* | |
| 5a | 1 | 85.12 ± 3.20 | 86.52 ± 2.1 | 88.21 ± 0.4 |
| 10 | 87.52 ± 2.5 | 87.90 ± 2.5 | 88.12 ± 1.6 | |
| 50 | 88.30 ± 1.5 | 88.10 ± 1.2 | 88.22 ± 7.0* | |
| 5b | 1 | 81.15 ± 6.30 | 82.24 ± 7.1 | 83.34 ± 2.4# |
| 10 | 81.93 ± 2.49 | 82.07 ± 1.8 | 84.13 ± 2.5 | |
| 50 | 87.72 ± 2.8 | 87.77 ± 2.8 | 88.8 ± 2.5* | |
| 5c | 1 | 34.21 ± 2.47 | 35.00 ± 2.12 | 36.52 ± 3.24# |
| 10 | 34.76 ± 1.3 | 35.13 ± 2.3 | 35.7 ± 1.77 | |
| 50 | 36.89 ± 1.26 | 37.17 ± 1.04 | 38.22 ± 1.5* | |
| 5d | 1 | 71.15 ± 2.22 | 72.25 ± 2.2 | 74.37 ± 1.45# |
| 10 | 72.12 ± 2.1 | 73.53 ± 1.24 | 75.9 ± 2.33 | |
| 50 | 73.12 ± 2.11 | 74.22 ± 2.15 | 76.12 ± 2.5 | |
| 6a | 1 | 66.21 ± 1.2 | 72.0.5 ± 1.09 | 77.37 ± 2.1# |
| 10 | 70.1.08 ± 0.5 | 73.153 ± 1.09 | 77.5 ± 0.33 | |
| 50 | 75.89 ± 2.1 | 77.17 ± 1.08 | 79.12 ± 0.5* | |
| 6b | 1 | 80.13 ± 2.30 | 81.20 ± 2.5 | 82.31 ± 2.0# |
| 10 | 81.23 ± 2.43 | 82.50 ± 1.8 | 84.15 ± 1.5 | |
| 50 | 85.72 ± 2.8 | 85.77 ± 2.8 | 88.8 ± 1.5* | |
| 6c | 1 | 40.95 ± 1.0 | 40.22 ± 1.1 | 41.09 ± 1.5# |
| 10 | 41.21 ± 1.2 | 41.40 ± 2.3 | 42.12 ± 1.5 | |
| 50 | 42.32 ± 2.1 | 43.02 ± 2.2 | 44.0 ± 2.1* | |
| 6d | 1 | 72.13 ± 1.55 | 72.33 ± 1.5 | 73.55 ± 1.5# |
| 10 | 73.11 ± 2.14 | 73.26 ± 1.7 | 74.12 ± 4.5 | |
| 50 | 74.19 ± 2.4 | 74.99 ± 7.3 | 75.2 ± 2.5 | |
| 6e | 1 | 80.15 ± 4.30 | 81.24 ± 7.1 | 82.34 ± 2.4# |
| 10 | 81.93 ± 2.49 | 81.07 ± 1.8 | 83.13 ± 1.5 | |
| 50 | 85.22 ± 2.5 | 85.72 ± 2.8 | 86.8 ± 2.5* | |
| Kocide 2000 | 2500 | 64.5 ± 1.5 | 65.2 ± 0.4 | 70.5 ± 0.5 |
| Itraconazole | 6.25 | 82.0 ± 1.5 | 89.0 ± 0.6 | 93.5 ± 0.5 |
Data shown in Table 3 are expressed as mean ± SD (Standard deviation);.
*Significant difference from positive control (Kocide 2000 compared to concentration of 50 µg/mL of the tested compounds) at p < 0.05.
#Significant difference from positive control (Itraconazole compared to concentration of 1 µg/mL of the tested compounds) at p < 0.05.